G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta-analysis and pharmacoeconomic evaluation-Reference-Cited by-同舟云学术

G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta-analysis and pharmacoeconomic evaluation

Published:1996-04 Issue:2 Volume:21 Page:57-63
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:

Author:

Messori A.,Trippoli S.,Tendi E.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2710.1996.tb00001.x/fullpdf

Reference24 articles.

1. Filgrastim-a review of its pharmacological properties and therapeutic efficacy in neutropenia;Frampton;Drugs,1994

2. Incidence of neutropenic fever in patients treated with standard dose-combination chemotherapy for small-cell lung cancer and the cost impact of treatment with granulocyte-colony-stimulating factor;Nichols;Journal Clinical Oncology,1994

3. Pharmacoeconomic evaluation of lenograstim: background, rationale, methodology and results;Mapelli;Pharmacoeconomics,1994

4. Cost considerations in therapy with myeloid growth factors;Glaspy;American Journal of Hospital Pharmacy,1993

5. Effectiveness of 5-aminosalicylic acid (5-ASA) for maintaining remission in patients with Crohn's disease: a meta-analysis;Messori;American Journal of Gastroenterology,1994

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evolution of value with filgrastim in oncology;Future Oncology;2019-05

2. Cost-effectiveness analysis of sensitive relapsed small-cell lung cancer based on JCOG0605 trial;Clinical and Translational Oncology;2017-11-02

3. Modern Radiotherapy in Limited and Extensive Stage Small-Cell Lung Cancer;Principles and Practice of Radiotherapy Techniques in Thoracic Malignancies;2016

4. Medical treatment of small cell lung cancer: state of the art and new development;Expert Opinion on Pharmacotherapy;2013-08

5. Treatment of patients with small-cell lung cancer: From meta-analyses to clinical practice;Cancer Treatment Reviews;2013-08